✦ LIBER ✦

Phase I Study of the Anti-MUC-l Antibody, huHMFG1 (AS1402), in Patients with Advanced Breast Cancer

✍ Scribed by Nigel Courtenay-Luck; Mark Pegram

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I dose escalation pharmacokinetic

✍ Mark D Pegram, Virginia F Borges, Nuhad Ibrahim, Jyotsna Fuloria… 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 178 KB

Population pharmacokinetics of the human

✍ Royer, B; Yin, W; Pegram, M; Ibrahim, N; Villanueva, C; Mir, D; Erlandsson, F; P 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 390 KB

Phase I safety, pharmacokinetic and phar

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Phase I study of a MUC1 vaccine composed

✍ Ramesh K. Ramanathan; Kenneth M. Lee; John McKolanis; Elizabeth Hitbold; Wolfgan 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 478 KB

A Phase I Study of Cetuximab/Paclitaxel

✍ Shanu Modi; Gabriella D'Andrea; Larry Norton; Tzy Jyun Yao; James Caravelli; Pet 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 379 KB

Phase I study of anti-VEGF monoclonal an

✍ Wheler, Jennifer J.; Janku, Filip; Falchook, Gerald S.; Jackson, Tiffiny L.; Fu, 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 386 KB